Skip to main content
. Author manuscript; available in PMC: 2008 Nov 21.
Published in final edited form as: Oncogene. 2007 Oct 15;27(15):2208–2214. doi: 10.1038/sj.onc.1210851

Figure 1.

Figure 1

Western blot analysis of Bcr-Abl and exogenous Bcr in TonB210 cells. (a) The indicated cells were cultured with or without doxycycline (1 μg ml−1) for 24h. Bcr-Abl was detected with anti-Abl 8E9 antibody at 1:8000 dilution. Anti-HA antibody was used to detect retroviral expressed Bcr to distinguish it from endogenous Bcr protein. (b) Cell proliferation and viability were measured by the MTT assay over a 3-day period as indicated following the induction of Bcr-Abl with 1 μg/ml of doxycycline for 72 h.